[Federal Register Volume 86, Number 95 (Wednesday, May 19, 2021)]
[Notices]
[Page 27092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10535]



[[Page 27092]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2019-N-5666, FDA-2011-N-0231, FDA-2010-N-0161, FDA-
2011-N-0275, and FDA-2013-D-0575]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Empirical Study of Promotional                 0910-0896       4/30/2023
 Implications of Proprietary
 Prescription Drug Names................
Adverse Experience Reporting for               0910-0308       4/30/2024
 Licensed Biological Products; and
 General Records........................
Export Certificates for FDA Regulated          0910-0498       4/30/2024
 Products...............................
Certification to Accompany Drug,               0910-0616       4/30/2024
 Biological Product, and Device
 Applications or Submissions............
Expedited Program for Serious Conditions-      0910-0765       4/30/2024
 Drugs and Biologics....................
------------------------------------------------------------------------


    Dated: May 14, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-10535 Filed 5-18-21; 8:45 am]
BILLING CODE 4164-01-P